In Vitro Anti-adenovirus Activity and Antioxidant Potential of Pistacia atlantica Desf. Leaves

Document Type: Original paper


1 Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

2 Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.

3 Student Research Committee, Shahrekord University of Medical Science, Shahrekord, Iran.



Background and objectives: Human adenoviruses cause a wide range of diseases, from self-limiting and mild infections to some life-threatening infections. Many studies have shown that components derived from medicinal plants have antiviral activity. Pistacia genus is rich in phenolic compounds and has antioxidant and antimicrobial effects. The aim of this study was to investigate antioxidant potential and antiviral effects of ethanol and crude extracts and different fractions of Pistacia atlantica Desf. leaves on adenovirus. Methods: Crude P. atlantica leaf extract was prepared by maceration with 80% ethanol. Hexane, chloroform, ethyl acetate and n-butanol fractions were prepared using liquid-liquid extraction method. Toxicity on HEp-2 cells and anti-adenoviral activity of the extract/fractions were evaluated by MTT colorimetric methods. The concentration that caused 50% viral inhibition (IC50) and 50 % cytotoxicity concentration (CC50) were evaluated using regression analysis. Selectivity index (SI), as a marker of antiviral activity, was calculated. To determine antioxidant activity the 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assay was used. Results: Ethyl acetate fraction showed the highest antioxidant activity with IC50of 1.54±0.12 μg/mL in DPPH scavenging assay. Based on our results, IC50 of P. atlantica crude extract on adenovirus was 15.72 μg/mL, with SI of 8.09; n-butanol fraction showed the highest anti-adenoviral activity among the fractions with IC50of 16.38 µg/mL and SI of 26.5. Conclusion: The ethanol extract and n-butanol fraction of P. atlantica leaves showed inhibitory effects on adenovirus and could be a new promising anti-adenovirus agent.


[1] Liu EB, Ferreyra L, Fischer SL, Pavan JV, Nates SV, Hudson NR, Tirado D, Dyer DW, Chodosh J, Seto D, Jones MS. Genetic analysis of a novel human adenovirus with a serologically unique hexon and a recombinant fiber gene. PLoS One. 2011; Article ID 24491.

[2] Lenaerts L, De Clercq E, Naesens L. Clinical features and treatment of adenovirus infections. Rev Med Virol. 2008; 18(6): 357-374.

[3] Lindemans CA, Leen AM, Boelens JJ. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood. 2010; 116(25): 5476-5485.

[4] Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014; 27(3): 441-462.

[5] Morfin F, Dupuis-Girod S, Mundweiler S, Falcon D, Carrington D, Sedlacek P, Bierings M, Cetkovsky P, Kroes AC, Van Tol MJ, Thouvenot D. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther. 2005; 10(2): 225-229.

[6] Matthes-Martin S, Feuchtinger T, Shaw PJ, Engelhard D, Hirsch HH, Cordonnier C, Ljungman P. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis. 2012; 14(6): 555-563.

[7] Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet. 1999; 36(2): 127-143.

[8] Bozorgi M, Memariani Z, Mobli M, Salehi Surmaghi MH, Shams-Ardekani MR, Rahimi R. Five Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): a review of their traditional uses, phytochemistry, and pharmacology. Sci World J. 2013; Article ID 219815.

[9] Rigane G, Ghazghazi H, Aouadhi C, Ben Salem R, Nasr Z. Phenolic content, antioxidant capacity and antimicrobial activity of leaf extracts from Pistacia atlantica. Nat Prod Res. 2017; 31(6): 696-699.

[10] Ozcelik B, Aslan M, Orhan I, Karaoglu T. Antibacterial, antifungal, and antiviral activities of the lipophylic extracts of Pistacia vera. Microbiol Res. 2005; 160(2): 159-164.

[11] Mouhajir F, Hudson JB, Rejdali M, Towers GHN. Multiple antiviral activities of endemic medicinal plants used by berber peoples of Morocco. Pharm Biol. 2008; 39(5): 364-374.

[12] Rashed K, Calland N, Deloison G, Rouille Y, Séron K. In-vitro antiviral activity of Pistacia chinensis flavonoids against hepatitis c virus (HCV). J Appl Pharm. 2014; 6(1): 8-18.

[13] Mohammadi-Kamalabadi M, Karimi A, Rafieian M, Amjad L. Phytochemical study and anti viral effect evaluation of methanolic extract with fractions of aerial parts of Euphorbia spinidens. J Babol Uni Med Sci. 2014; 16(5): 25-34.

[14] Moon JH, Terao J. Antioxidant activity of caffeic acid and dihydrocaffeic acid in lard and human low-density lipoprotein. J Agri Food Chem. 1998; 46(12): 5062-5065.

[15] Nahak DG, Sahu R. In vitro antioxidative acitivity of Azadirachta indica and Melia azedarach leaves by DPPH scavenging assay. Nature Sci. 2010; 8(4): 22-28.

[16] Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2): 55-63.

[17] Moradi MT, Karimi A, Alidadi S, Hashemi L. In vitro anti-herpes simplex virus activity, antioxidant potential and total phenolic compounds of selected Iranian medicinal plant extracts. Indian J Tradit Know. 2018; 17(2): 255-262.

[18] Jadhav P, Kapoor N, Thomas B, Lal H, Kshirsagar N. Antiviral potential of selected Indian medicinal (Ayurvedic) plants against herpes simplex virus 1 and 2. N Am J Med Sci. 2012; 4(12): 641-647.

[19] Peksel A, Arisan-atac I, Yanardag R. Evaluation of antioxidant and antiacetylcholinesterase activities of the extracts of Pistacia atlantica desf. leaves. J Food Biochem. 2010; 34(3): 451-476.

[20] Hatamnia AA, Rostamzad A, Hosseini M, Abbaspour N, Darvishzadeh R, Malekzadeh P, Aminzadeh BM. Antioxidant capacity and phenolic composition of leaves from 10 Bene (Pistacia atlantica subsp. kurdica) genotypes. Nat Prod Res. 2016; 30(5): 600-604.

[21] Cos P, Vlietinck AJ, Berghe DV, Maes L. Antiinfective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol. 2006; 106(3): 290-302.

[22] Pritchett JC, Naesens L, Montoya J. Treating HHV-6 infections: the laboratory efficacy and clinical use of anti-HHV-6 agents. In: Flamand L, Lautenschlager I, Krueger GRF, Ablashi DV, Eds. Human herpesviruses HHV-6A, HHV-6B & HHV-7. 3rd ed. Boston: Elsevier, 2014.

[23] Rezaie M, Farhoosh R, Pham N, Quinn RJ, Iranshahi M. Dereplication of antioxidant compounds in Bene (Pistacia atlantica subsp. mutica) hull using a multiplex approach of HPLC-DAD, LC-MS and (1)H NMR techniques. J Pharm Biomed Anal. 2016; 117: 352-362.

[24] Jassim SAA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol. 2003; 95(3): 412-427.

[25] Wang GF, Shi LP, Ren YD, Liu QF, Liu HF, Zhang RJ, Li Z, Zhu FH, He PL, Tang W, Tao PZ.  Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antiviral Res. 2009; 83(2): 186-190.